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Objective. To measure the incidence of ampicillin-resistant uropathogens in acute antepartum pyelonephritis and to determine
if patients with resistant organisms had diﬀerent clinical outcomes. Study design. This was a secondary analysis of a prospective
cohort study of pregnant women admitted with pyelonephritis, diagnosed by standard clinical and laboratory criteria. All patients
received ampicillin and gentamicin. Results. We identiﬁed 440 cases of acute pyelonephritis. Seventy-two percent (316 cases)
had urine cultures with identiﬁcation of organism and antibiotic sensitivities. Fifty-one percent of uropathogens were ampicillin
resistant. The patients with ampicillin-resistant organisms were more likely to be older and multiparous. There were no signiﬁcant
diﬀerences in hospital course (length of stay, days of antibiotics, ECU admission, or readmission). Patients with ampicillin-
resistantorganismsdidnothavehighercomplicationrates(anemia,renaldysfunction,respiratoryinsuﬃciency, orpretermbirth).
Conclusion. A majority of uropathogens were ampicillin resistant, but no diﬀerences in outcomes were observed in these patients.
Copyright © 2008 Laura G. Greer et al.ThisisanopenaccessarticledistributedundertheCreativeCommonsAttributionLicense,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1. INTRODUCTION
Acute pyelonephritis complicates 1-2% of all pregnancies,
making it one of the most common medical complications
of pregnancy [1]. Escherichia coli remains the most common
pathogen isolated in acute antepartum pyelonephritis, and
ampicillin has been a mainstay of treatment for antepartum
pyelonephritis because of eﬃcacy, cost, and minimal risk to
both the mother and fetus [2].
Because of its concomitant use in the prevention of
neonatal group B streptococcal sepsis, there is concern for
increasing trends of ampicillin-resistant organisms [2]. In
1984, Duﬀ reported a 22% incidence of ampicillin-resistant
E. coli in acute antepartum pyelonephritis. By 2001, Hart
reported a 45% incidence of ampicillin-resistant E. coli in
acute antepartum pyelonephritis [2, 3].
Globally, there are increasing rates of antibiotic-resistant
strains of E. coli [4]. This trend in antibiotic resistance
caused the Centers for Disease Control and Prevention
(CDC) to identify investigating the clinical implications
of antimicrobial resistance as a priority. Moreover, it has
been postulated that infections with antibiotic-resistant
organisms may increase the risk of treatment failures and
morbidity [2, 5, 6]. Accordingly, we sought to measure the
incidence of ampicillin resistance in uropathogens causing
acute pyelonephritis in our pregnant patient population
and to determine if resistant organisms resulted in diﬀerent
clinical outcomes.
2. MATERIALS AND METHODS
This is a secondary analysis of a prospective longitudinal
cohort study of 440 pregnant women diagnosed with acute
pyelonephritis [1]. The original cohort included all pregnant
women with antepartum pyelonephritis admitted to Park-
landMemorialHospital,Dallas,TX,USA,fromJanuary2000
to December 2001. The cohort study was exempted by the
Institutional Review Board.
The diagnosis of acute pyelonephritis was made with
clinical ﬁndings of fever (temperature ≥ 38
◦C), ﬂank pain,
and costovertebral angle tenderness along with laboratory
ﬁndings of pyuria or bacteriuria (≥20 bacteria per high
power ﬁeld). Clean catch mid-stream urine specimens or
catheterized urine specimens were collected for culture.2 Infectious Diseases in Obstetrics and Gynecology
Table 1: Uropathogens identiﬁed by culture with antibiotic sensitivities in acute antepartum pyelonephritis. Data are reported as n (%).
Organism Ampicillin-resistant Ampicillin-sensitive Total
n = 162(51) n = 155(49) n = 317
Escherichia coli 148 (51) 144 (49) 292 (92)
Klebsiella pneumoniae 11 (100) 0 (0) 11 (3)
Proteus mirabilis 0 (0) 8 (100) 8 (3)
Enterbacter sp. 3 (50) 3 (50) 6 (2)
Table 2: Comparison of demographic characteristics of women with
ampicillin-resistant versus ampicillin-sensitive uropathogens in acute
antepartum pyelonephritis. Data are reported as n ( % )o rm e a n±
standard deviation.
Ampicillin-resistant Ampicillin-sensitive P-value
n = 162 n = 155
Race 0.22
Black 12 (7) 19 (12)
White 6 (4) 11 (7)
Hispanic 142 (88) 124 (80)
Other 2 (1) 1 (1)
Nulliparous 49/133 (37) 65/132 (49) 0.04
The presumptive diagnosis of pyelonephritis, however, was
made and treatment initiated prior to receipt of culture
results. Antimicrobial therapy included intravenous ampi-
cillin two grams every six hours and intravenous gentamicin,
consisting of a loading dose of 120mg once followed by
80mg every eight hours.
Antimicrobial sensitivities were performed using a broth
microdilution and the study utilized breakpoints estab-
lished by the Clinical and Laboratory Standards Institute
(CLSI). Antimicrobial sensitivities were not performed on
uropathogens with colony counts of less than 100000.
Ampicillin resistance was deﬁned as a minimum inhibitory
concentration (MIC) greater than 16μg/mL.
Research nurses routinely entered pregnancy outcomes
and complications for all women delivered at Parkland Hos-
pital into a previously described, validated, and continuously
updated computerized obstetric database [7]. Antepartum
data on women with acute pyelonephritis were entered
into a separate research database that included length of
hospital stay, days of intravenous antibiotics received, vital
signs, respiratory insuﬃciency, necessity of admission to
an extended care unit, amount of IV ﬂuid received, and
laboratory evaluations including urine cultures, complete
blood count, and creatinine as previously described [1].
Anemia was deﬁned as a hematocrit less than 30%, and renal
dysfunction was deﬁned as creatinine ≥1.2mg/dL. Respira-
tory insuﬃciency was deﬁned as dyspnea, tachypnea, and
hypoxemia with radiological signs of pulmonary inﬁltrates
(information regarding intubation was not recorded).
The database created of antepartum pyelonephritis
patient outcomes included urine culture results by organism,
but it did not originally include information on antibi-
otic sensitivities. We subsequently re-examined the medical
records of the 440 patients admitted with acute pyelonephri-
tis to review the antibiotic sensitivities of the admission
urine cultures and entered these into the database. These
data were subsequently linked electronically to pregnancy
outcome data from the obstetric research database.
Statistical analyses were performed using SAS 9.1 (SAS
Institute, Cary, NC, USA). Comparisons were made with the
Pearson’s chi-square test for categorical data and Student’s t-
test for continuous data. Statistical normality was evaluated
using the Shapiro-Wilk statistic. For statistically nonnormal
data, the Wilcoxon rank-sum test was substituted for Stu-
dent’s t-test. The Mantel-Haenszel chi-square was used to
analyze trends in categorical data.
3. RESULTS
The original study included 440 patients with acute antepar-
tum pyelonephritis. Urine cultures with identiﬁcation of an
organism with suﬃcient colony forming units for antibiotic
sensitivity testing were available for 317 (72%) of the 440
initial study patients (72%). The organisms and resistance
rates are included in Table 1. Although additional patients
had positive urine cultures, our laboratory did not perform
antimicrobial sensitivities for cultures less than 100 000
colony-forming units.
Ninety-two percent (92%) of the cultures that had
organisms identiﬁed and sensitivities performed grew E.
coli. These results are summarized in Table 1. The other
organisms identiﬁed with suﬃcient colony-forming units to
receive antibiotic sensitivity testing included Klebsiella pneu-
moniae, Proteus mirabilis,a n dEnterbacter species. Overall,
ﬁfty-one percent (51%) of these organisms were resistant to
ampicillin.
We reviewed the demographic characteristics of the
patients with ampicillin-resistant and ampicillin-sensitive
organisms. As demonstrated in Table 2, there was no signiﬁ-
cant diﬀerence in the ethnicity of patients with ampicillin-
resistant organisms. The patients with ampicillin-resistant
organisms,however,weremorelikelytobemultiparous(P =
.04). The patients with ampicillin-resistant organisms were
also older (P = .04) (see Table 3).
We analyzed the hospital courses of women with acute
antepartum pyelonephritis comparing patients infected with
ampicillin-resistant and ampicillin-sensitive organisms. As
summarized in Table 4, we found no signiﬁcant diﬀerencesLaura G. Greer et al. 3
Table 3: Comparison of ages of women with ampicillin-resistant versus ampicillin-sensitive uropathogens in acute antepartum pyelonephritis.
Data are reported as n (%).
Ampicillin-resistant Ampicillin-sensitive Total P-value
n = 162 n = 155 n = 317
Age 0.04
15 or younger 1 (14) 6 (86) 7 (2)
>15 to <20 38 (49) 39 (51) 77 (24)
≥20 to <35 112 (51) 106 (49) 218 (69)
35 or older 11 (73) 4 (27) 15 (5)
Table 4: Summary of hospital stay of women with ampicillin-resistant versus ampicillin-sensitive uropathogens in acute antepartum
pyelonephritis. Data are reported as n (%) or mean ±standard deviation.
Ampicillin-resistant Ampicillin-sensitive P-value
n = 162 n = 155
Hospital days 3.6 ±1.73 .6 ±1.70 . 9 8
Days of IV antibiotics 3.5 ±1.63 .3 ±1.50 . 4 2
Extended care unit admission 21 (13) 16 (10) 0.47
Readmission 6 (3.7) 4 (2.6) 0.57
in length of hospital stay, days of IV antibiotics required,
admission to the extended care unit, or rate of hospital
readmission.
We also compared the rates of common complications
of acute antepartum pyelonephritis between the ampicillin-
resistant and ampicillin-sensitive groups. Patients with
ampicillin-resistant organisms did not have higher max-
imum temperatures (see Table 5). Additionally, infection
with ampicillin-resistant organisms was not associated with
increased rates of anemia, renal dysfunction, or respiratory
insuﬃciency. There was also no signiﬁcant diﬀerence in the
incidence of preterm birth between the two groups.
4. DISCUSSION
We re-evaluated a large prospective longitudinal study of
a cohort of women hospitalized with acute antepartum
pyelonephritis to measure the incidence of ampicillin resis-
tance in our patient population and to determine if resistant
organisms resulted in diﬀerent clinical outcomes.
Our review of the rate of ampicillin-resistance revealed
that the majority of organisms cultured were resistant to
ampicillin. As expected, E. coli was the most common
pathogen cultured in acute antenatal pyelonephritis, and
51% of E. coli cultures were ampicillin-resistant. This ﬁnding
is similar to Hart’s ﬁnding in 2001 of a 45% rate of
ampicillin-resistance in E. coli causing acute antepartum
pyelonephritis. Similarly, Gupta found that from 1992 to
1996, the rate of ampicillin resistance in E. coli isolates
increased from 26% to 34% in women with cystitis [8].
All the Klebsiella organisms cultured were ampicillin-
resistant, while all Proteus organisms cultured were
ampicillin-sensitive. Gupta reported a similar trend in
women with cystitis. Ninety-eight percent (98%) of
Klebsiella isolates were ampicillin-resistant, while only 8% of
Proteus species were ampicillin-resistant [8].
The initial report from this study found an 11.6% rate
of infection with Gram-positive organisms, and the majority
of these were identiﬁed as group B Streptococcus [1].
Our laboratory does not perform antimicrobial sensitivities
on group B Streptococcus or any other Gram-positive
uropathogens with less than 100000cfu.
Our analysis of demographic characteristics of women
with ampicillin-resistant organisms revealed no association
with ethnicity. It did, however, demonstrate that infection
with ampicillin-resistant organisms was more common in
older and multiparous patients. The observed trend of
increasing incidence of ampicillin-resistance with increasing
age and parity may be due to increased exposures to
antibiotics and to prior hospitalizations for deliveries. Either
of these events could increase their risk of acquiring resistant
organisms compared with patients who are younger and
nulliparous.
While the impact of infection with organisms resistant to
the initial antibiotic used to treat infection has been studied
in septic and ICU patients, no similar outcome studies
have been conducted in acute antepartum pyelonephritis. In
septic patients, infection with β-lactam resistant strains of E.
coli and Klebsiella resulted in signiﬁcantly higher mortality
rates[6].Otherstudiescomparingpatientoutcomesbetween
antibiotic-sensitive and antibiotic-resistant infections have
shown increased length of hospital stay, increased rates of
infectious complications, and increased cost of treatment
[9,10].Inlightofthesestudies,weundertookthis analysisto
assessifinfectionwithantibiotic-resistantorganismsinacute
antepartum pyelonephritis would aﬀect patient outcomes.
In acute antepartum pyelonephritis, infection with
organisms resistant to ampicillin did not aﬀect patient
outcomes in terms of the course of their hospital stay or4 Infectious Diseases in Obstetrics and Gynecology
Table 5: Comparison of hospital courses of women with ampicillin-resistant versus ampicillin-sensitive uropathogens in acute antepartum
pyelonephritis. Data are reported as n (%) or mean ±standard deviation.
Ampicillin-resistant Ampicillin-sensitive P-value
Maximum temperature 38.7
◦C ±0.83 8 .7
◦C ±0.90 . 7 9
Anemia
1 39 (24) 35 (23) 0.75
Renal dysfunction
2 2 (1) 1 (1) 0.59
Respiratory insuﬃciency
3 15 (9) 13 (8) 0.79
Preterm birth in weeks
<37 estimated gestational age 7 (5) 5 (4) 0.56
<32 estimated gestational age 4 (3) 2 (2) 0.41
1Anemia was deﬁned as a hematocrit less than 30%.
2Renal dysfunction was deﬁned as a creatinine ≥1.2mg/dL.
3Respiratory insuﬃciency was deﬁned as dyspnea, tachypnea, and hypoxemia with radiological signs of pulmonary inﬁltrate.
the frequency of common complications of pyelonephritis.
The similarities in outcomes between patients infected with
ampicillin-resistant and ampicillin-sensitive organisms are
reassuring in light of the common use of ampicillin and
gentamicin to treat acute antepartum pyelonephritis and the
increasing reports of ampicillin-resistant organisms. There
are several possible explanations for this ﬁnding.
The ﬁrst explanation is that while over ﬁfty percent
of the organisms cultured were resistant to ampicillin, all
patients were receiving gentamicin in addition to ampicillin.
Moreover, only a single patient had an organism that was
resistant to gentamicin. Ampicillin and gentamicin may
create a pharmacologic synergy that may also explain the
discrepancy between in vitro susceptibilities and in vivo
ﬁndings [11]. This also raises the question of whether
treatment with gentamicin alone would be adequate to treat
the majority of cases of acute antepartum pyelonephritis.
The second explanation is that while these organisms
were microbiologically resistant to ampicillin, they may not
have been clinically resistant to ampicillin. That is, resistance
h a sb e e nd e ﬁ n e di nan u m b e ro fd i ﬀerent ways. It can be
deﬁned genetically (genotypically), meaning that there is a
geneticmechanisminthebacteriathatencodesforresistance
against a class of antibiotics. Alternatively, resistance can be
deﬁned, as it was here, microbiologically (phenotypically)
meaning that there is an abnormally elevated minimum
inhibitory concentration (MIC) observed in laboratory
testing. Finally, resistance can be deﬁned clinically as the
failure to demonstrate improvement in the patient receiving
the medication [6].
Wing et al. alluded to this diﬀerence in microbiological
resistance versus clinical resistance in their assessment of
the utility of blood and urine culture results in acute
antepartumpyelonephritis[12].Intheirstudy,somepatients
were receiving ampicillin and gentamicin while others were
receiving monotherapy with a ﬁrst-generation or third-
generation cephalosporin. Although they had ampicillin
resistance rates of 46% and ﬁrst-generation cephalosporin
resistance rates of 7%, 94% of patients were given appropri-
ate antibiotics when “appropriate antibiotics” were deﬁned
as clinical improvement. They found only 6% of patients
had changes in antibiotic regimen. Of these, the majority
of changes were due to perceived lack of clinical response,
including persistent fever beyond 72hours, rather than
due to the sensitivity results of the cultures [12]. This
ﬁnding led Wing et al. to conclude that blood and urine
cultures with sensitivities have limited practical utility in the
majority of patients with acute antepartum pyelonephritis.
While we believe that culture results continue to have a
role in determining the organisms causing infection, the
success of therapy in sterilizing the urine, and the antibiotic
resistance rates within our hospital, we agree that changes in
antimicrobial therapy should be guided by clinical response
rather than solely based on culture results.
Our study has several limitations. First, we included only
patients managed as inpatients, and our ﬁndings may not
apply to populations managed as outpatients. Second, the
only patients who had cultures with antibiotic sensitivities
were those with Gram-negative organisms, so we do not
know the rate of ampicillin resistance in other pathogens
or whether ampicillin resistance in those organisms would
aﬀect outcomes.
5. CONCLUSIONS
In summary, we found no association with adverse clinical
outcomes in gravidas with acute pyelonephritis treated
with ampicillin and gentamicin that had ampicillin-resistant
Gram-negative uropathogens. These data should reassure
clinicians that this well-established treatment regimen is
still eﬀective in the management of acute antepartum
pyelonephritis in most settings.
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